Drug Type CAR-T |
Synonyms LCARBCX CAR cell therapy Nanjing Legend Biotech, LCAR-BCX |
Target |
Action inhibitors |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Refractory Multiple Myeloma | Phase 1 | China | 09 Oct 2020 | |
Relapse multiple myeloma | Phase 1 | China | 09 Oct 2020 |